Plain-English translation of NCT06861673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether two heart procedures can be safely and effectively performed together in a single session. The first procedure uses a newer ablation technology called pulsed field ablation to restore your heart's normal rhythm by isolating the pulmonary veins. The second procedure places a small device called WATCHMAN Flx in your heart to reduce stroke risk by closing an opening where clots can form. Researchers believe doing both at once may be safer and faster than doing them separately.
Many patients with irregular heartbeat cannot take blood-thinning medications due to bleeding risk or other medical reasons, making the protective device an important alternative. By combining these two procedures into one session using this newer ablation technology, doctors hope to reduce overall procedure time, lower complication rates, and improve outcomes for patients who need both treatments.
You likely qualify if…
You likely don't qualify if…
You would undergo a combined procedure where doctors perform both the heart rhythm treatment and place the protective device in a single session. About two months after the successful procedure, you may be able to stop taking certain blood-thinning medications. Researchers will track your safety, how well the procedures worked, and any complications that occur.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Germany